Patient-reported outcomes and treatment preferences in 1,900 men with prostate cancer participating in two international, randomised clinical trials

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Men with high-risk or metastatic prostate cancer are faced with difficult and uncertain trade-offs between quantity and quality of life when making a treatment decision. The proposed study extends two promising, ongoing clinical trials by describing the quality of life outcomes and treatment.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2022

Funding Scheme: Early Career Fellowships

Funding Amount: $318,768.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

consumer preferences | outcome assessment | outcome measures | prostate cancer | quality of life